España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Cardiol Therapeutics
CRDL
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
Get Report
Comment
Cardiol Therapeutics (CRDL) Forecast
News
Earnings
Cardiol Therapeutics (CRDL) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Cardiol Therapeutics (NASDAQ:CRDL) Stock
Cardiol Therapeutics Stock (NASDAQ: CRDL)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, December 18, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Wednesday, November 20, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Tuesday, November 19, 2024
CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study
Nina Zdinjak
Monday, November 18, 2024
Cardiol Therapeutics' Presents Phase II MAvER...
Benzinga Newsdesk
Thursday, October 24, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Tuesday, October 22, 2024
Cardiol Therapeutics Plans To Expand MAVERIC ...
Benzinga Newsdesk
Wednesday, October 09, 2024
Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today
Henry Khederian
Cardiol Therapeutics shares are trading lower...
Benzinga Newsdesk
Cardiol Therapeutics Announces Pricing Of $13...
Benzinga Newsdesk
AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor
Tuesday, October 08, 2024
Cardiol Therapeutics shares are trading lower...
Benzinga Newsdesk
Cardiol Therapeutics Files Preliminary Prospe...
Benzinga Newsdesk
Tuesday, September 24, 2024
Cardiol Therapeutics Says Achieved Target Pat...
Benzinga Newsdesk
Tuesday, September 10, 2024
Cardiol Therapeutics Concludes MAvERIC Phase ...
Benzinga Newsdesk
Wednesday, June 26, 2024
Roth MKM Initiates Coverage On Cardiol Therap...
Benzinga Newsdesk
Friday, June 14, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Thursday, June 13, 2024
Cardiol Therapeutics shares are trading lower...
Benzinga Newsdesk
Cardiol Therapeutics Presented Topline Data F...
Benzinga Newsdesk
Friday, June 07, 2024
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Thursday, May 23, 2024
Canaccord Genuity Maintains Buy on Cardiol Th...
Benzinga Newsdesk
Tuesday, May 14, 2024
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
Nicolás Jose Rodriguez
HC Wainwright & Co. Reiterates Buy on Cardiol...
Benzinga Newsdesk
Monday, April 22, 2024
HC Wainwright & Co. Initiates Coverage On Car...
Benzinga Newsdesk
Tuesday, April 02, 2024
Cardiol Therapeutics Q4 EPS $(0.09) Beats $(0...
Benzinga Newsdesk
Cardiol Therapeutics' Cash And Cash Equivalen...
Benzinga Newsdesk
Thursday, February 15, 2024
Cardiol Therapeutics shares are trading highe...
Benzinga Newsdesk
Cardiol Therapeutics Says FDA Granted Orphan ...
Benzinga Newsdesk
Tuesday, January 09, 2024
Cardiol Therapeutics Exceeds 50% Enrollment I...
Benzinga Newsdesk
Thursday, October 12, 2023
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations
Beau Sharpe
Tuesday, October 10, 2023
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
Jelena Martinovic
Thursday, September 21, 2023
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Lisa Levin
Tuesday, September 19, 2023
Cardiol Therapeutics Announces All Collaborat...
Benzinga Newsdesk
Monday, August 14, 2023
Cantor Fitzgerald Reiterates Overweight on Ca...
Benzinga Newsdesk
Friday, May 19, 2023
Canaccord Genuity Maintains Buy on Cardiol Th...
Benzinga Newsdesk
Tuesday, January 17, 2023
Reported Earlier, Cardiol Therapeutics Says F...
Benzinga Newsdesk
Monday, November 14, 2022
Cardiol Therapeutics Receives Nasdaq Deficien...
Benzinga Newsdesk
Friday, October 21, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Wednesday, October 19, 2022
Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights
Tuesday, October 18, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Tuesday, October 11, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 10, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Friday, October 07, 2022
Stocks That Hit 52-Week Lows On Friday
Benzinga Insights
Tuesday, October 04, 2022
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Monday, October 03, 2022
Stocks That Hit 52-Week Lows On Monday
Benzinga Insights
Cardiol Therapeutics Announces Pre-Clinical S...
Benzinga Newsdesk
Thursday, June 09, 2022
Cardiol Therapeutics Announces At-The-Market ...
Benzinga Newsdesk
Thursday, May 19, 2022
76 Biggest Movers From Yesterday
Lisa Levin
Tuesday, May 17, 2022
FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis
Ragothaman Srinivasan
Cardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization For Multicenter Phase II Open-Label Pilot Study Of CardiolRx For Recurrent Pericarditis
Bill Haddad
Tuesday, April 19, 2022
68 Biggest Movers From Yesterday
Lisa Levin
Show More
